Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
59,770,937
-
Shares change
-
-1,480,770
-
Total reported value, excl. options
-
$1,417,172,672
-
Value change
-
-$63,863,484
-
Put/Call ratio
-
7.7%
-
Number of buys
-
68
-
Number of sells
-
-112
-
Price
-
$23.71
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q3 2014
208 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q3 2014.
IMPAX LABORATORIES INC - COM (IPXL) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,770,937 shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6,405,200 shares), BlackRock Fund Advisors (4,698,460 shares), VANGUARD GROUP INC (4,486,056 shares), Invesco Ltd. (3,575,594 shares), State Street Corp (2,722,222 shares), Slate Path Capital LP (2,330,000 shares), FMR LLC (2,297,183 shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2,232,414 shares), BlackRock Institutional Trust Company, N.A. (1,836,462 shares), and Ameriprise Financial Inc (1,544,771 shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.